Send us a text

Christopher Guiliano, clinical pharmacist, is back on The Rounds Table with Carrie Hartner, clinical pharmacist in the medical intensive care unit.  Together they cover rivaroxaban in preventing thrombosis in patients with Anti-phospholipid syndrome (APS) and in patients with cancer. The prevalence of APS is 50 in 100,000 patients and it is associated with arterial and ...

The post Believe It or Clot: Rivaroxaban in Preventing Thrombosis in Anti-Phospholipid Syndrome and in Cancer appeared first on Healthy Debate.